Kensuke Nishi1,2, Shohei Yoshimoto3, Soichiro Nishi2, Toshiyuki Tsunoda4, Jun Ohno5, Michinobu Yoshimura6, Kenji Hiromatsu6, Takafumi Yamano7. 1. Section of Otolaryngology, Department of Medicine, Fukuoka Dental College, Fukuoka, Japan; knishi@college.fdcnet.ac.jp. 2. Nishi Otolaryngology Clinic, Fukuoka, Japan. 3. Section of Pathology, Department of Morphological Biology, Division of Biomedical Sciences, Fukuoka Dental College, Fukuoka, Japan. 4. Department of Cell Biology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan. 5. Research Center for Regenerative Medicine, Fukuoka Dental College, Fukuoka, Japan. 6. Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan. 7. Section of Otolaryngology, Department of Medicine, Fukuoka Dental College, Fukuoka, Japan.
Abstract
BACKGROUND: The epipharynx, with its high expression of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) entry factors angiotensin-converting enzyme 2 (ACE2) and transmembrane protease, serine 2 (TMPRSS2), is a primary target for SARS-CoV-2 replication in the early stage of Coronavirus Disease 19 (COVID-19). Epipharyngeal abrasive therapy (EAT) is a treatment for epipharyngitis in Japan which involves applying zinc chloride to the epipharyngeal mucosa. In this study, we evaluated the expression patterns of ACE2 and TMPRSS2 in tissue samples from patients before and after EAT. PATIENTS AND METHODS: The study subjects were seven patients that had not been treated with EAT and 11 patients that had. For immunohistochemical assessment of the epipharyngeal mucosa, the staining intensity of ACE2 and TMPRSS2 was described as an immunohistochemical score (IHC score). RESULTS: The IHC scores for ACE2 and TEMPRSS2 in the EAT-treated group were 3.40-fold and 1.81-fold lower, respectively, than those in the non-treated group (p=0.0208 and p=0.0244, respectively). CONCLUSION: EAT down-regulates the expression of SARS-CoV-2 entry factors ACE2 and TMPRSS2. Thus, EAT has potential as a novel COVID-19 preventative method.
BACKGROUND: The epipharynx, with its high expression of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) entry factors angiotensin-converting enzyme 2 (ACE2) and transmembrane protease, serine 2 (TMPRSS2), is a primary target for SARS-CoV-2 replication in the early stage of Coronavirus Disease 19 (COVID-19). Epipharyngeal abrasive therapy (EAT) is a treatment for epipharyngitis in Japan which involves applying zinc chloride to the epipharyngeal mucosa. In this study, we evaluated the expression patterns of ACE2 and TMPRSS2 in tissue samples from patients before and after EAT. PATIENTS AND METHODS: The study subjects were seven patients that had not been treated with EAT and 11 patients that had. For immunohistochemical assessment of the epipharyngeal mucosa, the staining intensity of ACE2 and TMPRSS2 was described as an immunohistochemical score (IHC score). RESULTS: The IHC scores for ACE2 and TEMPRSS2 in the EAT-treated group were 3.40-fold and 1.81-fold lower, respectively, than those in the non-treated group (p=0.0208 and p=0.0244, respectively). CONCLUSION: EAT down-regulates the expression of SARS-CoV-2 entry factors ACE2 and TMPRSS2. Thus, EAT has potential as a novel COVID-19 preventative method.
Authors: Jesper D Gunst; Nina B Staerke; Marie H Pahus; Lena H Kristensen; Jacob Bodilsen; Nicolai Lohse; Lars S Dalgaard; Dorthe Brønnum; Ole Fröbert; Bo Hønge; Isik S Johansen; Ida Monrad; Christian Erikstrup; Regitze Rosendal; Emil Vilstrup; Theis Mariager; Dorthe G Bove; Rasmus Offersen; Shakil Shakar; Sara Cajander; Nis P Jørgensen; Sajitha S Sritharan; Peter Breining; Søren Jespersen; Klaus L Mortensen; Mads L Jensen; Lilian Kolte; Giacomo S Frattari; Carsten S Larsen; Merete Storgaard; Lars P Nielsen; Martin Tolstrup; Eva A Sædder; Lars J Østergaard; Hien T T Ngo; Morten H Jensen; Jesper F Højen; Mads Kjolby; Ole S Søgaard Journal: EClinicalMedicine Date: 2021-04-22
Authors: Mohammad Rubayet Hasan; Muneera Naseer Ahmad; Soha Roger Dargham; Hatem Zayed; Alaa Al Hashemi; Nonhlanhla Ngwabi; Andres Perez Lopez; Simon Dobson; Laith Jamal Abu Raddad; Patrick Tang Journal: Microbiol Spectr Date: 2021-11-03
Authors: Soeren Lukassen; Robert Lorenz Chua; Timo Trefzer; Nicolas C Kahn; Marc A Schneider; Michael Kreuter; Christian Conrad; Roland Eils; Thomas Muley; Hauke Winter; Michael Meister; Carmen Veith; Agnes W Boots; Bianca P Hennig Journal: EMBO J Date: 2020-04-14 Impact factor: 11.598